These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 51837)

  • 1. Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
    Armbruster H; Vetter W; Reck G; Beckerhoff R; Siegenthaler W
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):170-3. PubMed ID: 51837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V; Parisio E; Ricci G
    Minerva Med; 1987 Sep; 78(17):1305-11. PubMed ID: 2444906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential therapeutic principles in the drug therapy of high blood pressure].
    Rahn KH
    Internist (Berl); 1974 Mar; 15(3):157-64. PubMed ID: 4151964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone].
    Virgolini L; Geatti O; Giunta G
    Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arterial hypertension induced by an excess of mineralocorticoids caused by abuse of nasal spray. Report of a case].
    De Venuto G; Mattarei M; Dal Piaz A; De Santa A; Torboli PL; Miori R
    Minerva Med; 1984 Jun; 75(27):1673-77. PubMed ID: 6205328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factitious hypertension with mineralocorticoid excess in an infant.
    De Stefano P; Bongo IG; Borgna-Pignatti C; Severi F
    Helv Paediatr Acta; 1983 May; 38(2):185-9. PubMed ID: 6874387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
    Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G
    Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
    Montoliu J; Botey A; Trilla A; Revert L
    Clin Nephrol; 1984 Nov; 22(5):262-6. PubMed ID: 6394185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autometrically and automatically monitored, iatrogenous, inhalant-decongestant-associated high blood pressure quantified by rhythmometry.
    Scarpelli PT; Scarpelli L; Livi R; Groppi E; Cornélissen G; Romano S; Cagnoni M; Halberg F
    Prog Clin Biol Res; 1987; 227B():183-200. PubMed ID: 2442774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension treatable with glucocorticoids: report of a case].
    Montero J; Fardella C; Mosso L
    Rev Med Chil; 1997 Nov; 125(11):1361-5. PubMed ID: 9609059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antihypertensive therapy.
    Simpson FO
    Cardiovasc Clin; 1971; 2(3):37-54. PubMed ID: 4149975
    [No Abstract]   [Full Text] [Related]  

  • 16. Low renin essential hypertension in a child.
    Leumann EP; Nussberger J; Vetter W
    Helv Paediatr Acta; 1976 Jan; 30(4-5):357-63. PubMed ID: 1245435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for hypertension.
    Med Lett Drugs Ther; 1977 Mar; 19(5):21-4. PubMed ID: 840157
    [No Abstract]   [Full Text] [Related]  

  • 18. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
    Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)].
    Vasconez F; Pérez-Garcia R; Olivas E; Bolívar JE; Valderrábano F
    Med Clin (Barc); 1980 Dec; 75(10):430-4. PubMed ID: 7464329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.